Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19003
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNaidu, Pratyusha-
dc.contributor.authorChurilov, Leonid-
dc.contributor.authorKong, Alvin-
dc.contributor.authorKanaan, Richard A A-
dc.contributor.authorWong, Henry K-
dc.contributor.authorVan Mourik, Arielle-
dc.contributor.authorYao, Anthony-
dc.contributor.authorCornish, Elizabeth-
dc.contributor.authorHachem, Mariam-
dc.contributor.authorHart, Graeme K-
dc.contributor.authorOwen-Jones, Elizabeth-
dc.contributor.authorRobbins, Raymond J-
dc.contributor.authorLam, Que T-
dc.contributor.authorSamaras, Katherine-
dc.contributor.authorZajac, Jeffrey D-
dc.contributor.authorEkinci, Elif I-
dc.date2017-03-28-
dc.date.accessioned2018-09-12T23:57:45Z-
dc.date.available2018-09-12T23:57:45Z-
dc.date.issued2017-03-28-
dc.identifier.citationFrontiers in Endocrinology 2017; 8: 53en_US
dc.identifier.issn1664-2392-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/19003-
dc.description.abstractUsing routine hemoglobin A1c (HbA1c) testing to describe the prevalence, characteristics, and length of stay (LOS) of psychiatry inpatients with type 2 diabetes compared to those with pre-diabetes and those without diabetes. In this prospective observational study, all inpatients aged greater than 30 years admitted to the Austin Health Psychiatry Unit, a major tertiary hospital, affiliated with the University of Melbourne, between February 2014 and April 2015 had routine HbA1c testing as part of the Diabetes Discovery Initiative. Patients were divided into three groups: diabetes (HbA1c ≥ 6.5%, 48 mmol/mol), pre-diabetes (HbA1c 5.7-6.4%, 39-46 mmol/mol), or no diabetes (HbA1c ≤ 5.6%, 38 mmol/mol). Baseline characteristics, co-morbidities, psychiatric illnesses, and treatment were recorded. There were a total of 335 psychiatry inpatients (median age 41 years). The most prevalent diagnoses were schizophrenia, depression, and substance abuse. Of the 335 psychiatric inpatients, 14% (n = 46) had diabetes and 19% (n = 63) had pre-diabetes, a prevalence threefold greater than in the aged matched general population. Compared to inpatients with pre-diabetes and no diabetes, those with diabetes were older and were at least twice as likely to have hypertension, obesity, and hyperlipidemia (all p ≤ 0.002). In multivariable analyses, diabetes was associated with increasing age (p = 0.02), substance abuse (p = 0.04), dyslipidaemia (p = 0.03), and aripiprazole use (p = 0.01). Patients with diabetes also had a 70% longer expected LOS (95% CI: 20-130%; p = 0.001), compared to those with pre-diabetes and no diabetes. Despite relative youth, one-third of all psychiatric inpatients above the age of 30 have diabetes or pre-diabetes. Presence of diabetes in psychiatric inpatients is associated with older age, substance abuse, and longer LOS. Routine inpatient HbA1c testing provides an opportunity for early detection and optimization of diabetes care.en_US
dc.language.isoeng-
dc.subjectatypical antipsychoticsen_US
dc.subjectdiabetesen_US
dc.subjectobesityen_US
dc.subjectpre-diabetesen_US
dc.subjectpsychiatry inpatientsen_US
dc.titleUsing Routine Hemoglobin A1c Testing to Determine the Glycemic Status in Psychiatric Inpatients.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleFrontiers in Endocrinologyen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.affiliationEndocrinologyen_US
dc.identifier.affiliationFaculty of Medicine, St Vincent's Clinical School, UNSW, Sydney, NSW, Australiaen_US
dc.identifier.affiliationDepartment of Endocrinology, St Vincent's Hospital, Sydney, NSW, Australiaen_US
dc.identifier.affiliationPathologyen_US
dc.identifier.affiliationDepartment of Administrative Informatics, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationAustin Centre for Applied Clinical Informatics, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationIntensive Careen_US
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen_US
dc.identifier.affiliationMenzies School of Health Research, Darwin, Victoria, Australiaen_US
dc.identifier.affiliationGeneral Medicineen_US
dc.identifier.affiliationPsychiatry (University of Melbourne)en_US
dc.identifier.doi10.3389/fendo.2017.00053en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-0992-1917en_US
dc.identifier.orcid0000-0002-9807-6606en_US
dc.identifier.orcid0000-0003-3838-8795en_US
dc.identifier.orcid0000-0003-2372-395Xen_US
dc.identifier.pubmedid28396652-
dc.type.austinJournal Article-
local.name.researcherChurilov, Leonid
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptPsychiatry (University of Melbourne)-
crisitem.author.deptOphthalmology-
crisitem.author.deptIntensive Care-
crisitem.author.deptClinical Analytics and Reporting-
crisitem.author.deptPathology-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on Apr 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.